DSRU plans ‘post-authorisation’ study of COVID-19 vaccines in the UK
Drug Safety Research Unit set to conduct active surveillance study on COVID-19 vaccines
Read More
Tag: Safety study
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
